DAVID GRANOVSKY

Higher bleeding risk seen in J&J, Bayer clot drug – Reuters Health Report

In OFF THE BEATEN PATH on April 5, 2011 at 9:43 pm
Higher bleeding risk seen in J&J, Bayer clot drug
April 05, 2011 09:35 AM ET
NEW ORLEANS (Reuters) – A blood clot preventer from Johnson & Johnson and Bayer caused a surprisingly high rate of bleeding in a trial of patients with acute illnesses, representing a significant setback for the drugmakers. | Full Article

https://i0.wp.com/boogey.me/wp-content/themes/mixedmediared/images/DrippingBlood.png

Gmail – Reuters Health Report – dsgrano@gmail.com.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: